We compared changes in blood glucose (BG) and risk of hypoglycaemia during and after exercise in 40 patients with type 1 diabetes (T1D) treated with insulin degludec (IDeg) or insulin glargine (IGlar) in a randomized, open-label, two-period, crossover trial. After individual titration and a steady-state period, patients performed 30 min of moderate-intensity cycle ergometer exercise (65
作者：T, Heise；S C, Bain；R M, Bracken；E, Zijlstra；L, Nosek；K, Stender-Petersen；R, Rab?l；E, Rowe；H L, Haahr
来源：Diabetes, obesity & metabolism 2016 年 18卷 2期
